✦ LIBER ✦

Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics

✍ Scribed by K. Pavelka; Š. Forejtová; A. Pavelková; J. Zvárová; J. Rovenský; A. Tuchyňová

Publisher: Springer
Year: 2002
Tongue: English
Weight: 225 KB
Volume: 21
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-002-8289-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind study on the effect of di

A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis

✍ H. Leeden; B. A. C. Dijkmans; J. Hermans; A. Cats 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 343 KB

Etanercept and adalimumab treatment in p

Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

✍ Tiina Levälampi; Markku Korpela; Katriina Vuolteenaho; Eeva Moilanen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 341 KB

Tuberculosis infection in patients with

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

✍ Frederick Wolfe; Kaleb Michaud; Janice Anderson; Kathy Urbansky 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions

CTLA4 exon1 A49G polymorphism in Slovak

CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis—results and the review of the literature

✍ Karim Benhatchi; Ivana Jochmanová; Viera Habalová; Hedviga Wagnerová; Ivica Lazú 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 116 KB

Single-center, retrospective analysis of

Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis

✍ Michihiro Ogasawara; Naoto Tamura; Michiaki Kageyama; Shin Onuma; Makio Kusaoi; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 489 KB

The long-term effect of methotrexate the

The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis

✍ Philip J. Hashkes; William F. Balistreri; Kevin E. Bove; Edgar T. Ballard; Murra 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 956 KB